235 related articles for article (PubMed ID: 23792823)
1. Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.
Tang HY; Beer LA; Tanyi JL; Zhang R; Liu Q; Speicher DW
J Proteomics; 2013 Aug; 89():165-78. PubMed ID: 23792823
[TBL] [Abstract][Full Text] [Related]
2. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.
Tang HY; Beer LA; Chang-Wong T; Hammond R; Gimotty P; Coukos G; Speicher DW
J Proteome Res; 2012 Feb; 11(2):678-91. PubMed ID: 22032327
[TBL] [Abstract][Full Text] [Related]
3. Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera.
Beer LA; Wang H; Tang HY; Cao Z; Chang-Wong T; Tanyi JL; Zhang R; Liu Q; Speicher DW
PLoS One; 2013; 8(3):e60129. PubMed ID: 23544127
[TBL] [Abstract][Full Text] [Related]
4. The impact of tropomyosins on actin filament assembly is isoform specific.
Janco M; Bonello TT; Byun A; Coster AC; Lebhar H; Dedova I; Gunning PW; Böcking T
Bioarchitecture; 2016 Jul; 6(4):61-75. PubMed ID: 27420374
[TBL] [Abstract][Full Text] [Related]
5. CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer.
Singha B; Harper SL; Goldman AR; Bitler BG; Aird KM; Borowsky ME; Cadungog MG; Liu Q; Zhang R; Jean S; Drapkin R; Speicher DW
Sci Rep; 2018 Oct; 8(1):14725. PubMed ID: 30282979
[TBL] [Abstract][Full Text] [Related]
6. Identification, characterization, and expression of sarcomeric tropomyosin isoforms in zebrafish.
Dube DK; Dube S; Abbott L; Wang J; Fan Y; Alshiekh-Nasany R; Shah KK; Rudloff AP; Poiesz BJ; Sanger JM; Sanger JW
Cytoskeleton (Hoboken); 2017 Mar; 74(3):125-142. PubMed ID: 27998020
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide and protein sequences for dog masticatory tropomyosin identify a novel Tpm4 gene product.
Brundage EA; Biesiadecki BJ; Reiser PJ
J Muscle Res Cell Motil; 2015 Oct; 36(4-5):339-347. PubMed ID: 26400443
[TBL] [Abstract][Full Text] [Related]
8. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of tropomyosin isoforms in skeletal muscles by top-down proteomics.
Jin Y; Peng Y; Lin Z; Chen YC; Wei L; Hacker TA; Larsson L; Ge Y
J Muscle Res Cell Motil; 2016 Apr; 37(1-2):41-52. PubMed ID: 27090236
[TBL] [Abstract][Full Text] [Related]
10. Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay.
Ryu J; Boylan KLM; Twigg CAI; Evans R; Skubitz APN; Thomas SN
Clin Proteomics; 2024 Jan; 21(1):1. PubMed ID: 38172678
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor tropomyosin Tpm2.1 regulates sensitivity to apoptosis beyond anoikis characterized by changes in the levels of intrinsic apoptosis proteins.
Desouza-Armstrong M; Gunning PW; Stehn JR
Cytoskeleton (Hoboken); 2017 Jun; 74(6):233-248. PubMed ID: 28378936
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of beta-tropomyosin (Tpm2) and duplication of the alpha-slow tropomyosin gene (TPM3) in Atlantic salmon Salmo salar.
Silva AMM; Kennedy LS; Hasan SC; Cohen AM; Heeley DH
Comp Biochem Physiol B Biochem Mol Biol; 2020 Jul; 245():110439. PubMed ID: 32283206
[TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Properties of Tropomyosin Isoforms Tpm4.1 and Tpm2.1.
Logvinov AS; Nefedova VV; Yampolskaya DS; Kleymenov SY; Levitsky DI; Matyushenko AM
Biochemistry (Mosc); 2023 Jun; 88(6):801-809. PubMed ID: 37748876
[TBL] [Abstract][Full Text] [Related]
14. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
15. Tropomyosin isoforms differentially modulate the regulation of actin filament polymerization and depolymerization by cofilins.
Robaszkiewicz K; Ostrowska Z; Marchlewicz K; Moraczewska J
FEBS J; 2016 Feb; 283(4):723-37. PubMed ID: 26663234
[TBL] [Abstract][Full Text] [Related]
16. Novel human cell expression method reveals the role and prevalence of posttranslational modification in nonmuscle tropomyosins.
Carman PJ; Barrie KR; Dominguez R
J Biol Chem; 2021 Oct; 297(4):101154. PubMed ID: 34478714
[TBL] [Abstract][Full Text] [Related]
17. Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
Humayun-Zakaria N; Arnold R; Goel A; Ward D; Savill S; Bryan RT
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30836651
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
Stevens EV; Liotta LA; Kohn EC
Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
20. Expression of a novel cardiac-specific tropomyosin isoform in humans.
Denz CR; Narshi A; Zajdel RW; Dube DK
Biochem Biophys Res Commun; 2004 Aug; 320(4):1291-7. PubMed ID: 15249230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
